07/18/2025
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
5:30 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
6:00 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2025
3:27 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
5:00 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/02/2025
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:06 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:07 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:07 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:07 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:08 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:08 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:09 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:22 AM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
8:22 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:32 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:32 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:33 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:33 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:33 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
5:34 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:30 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
4:36 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:05 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
4:30 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
3:20 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2025
6:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
7:13 AM | Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
11:24 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/13/2025
8:11 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
5:47 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
9:44 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
6:14 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2025
6:18 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
05/08/2025
6:34 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
3:41 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2025
5:22 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
7:00 AM | Akero Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
7:23 AM | Akero Therapeutics (Filer)
| Form ARS | |
04/16/2025
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
5:00 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
5:00 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
3:24 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
6:42 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:30 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
8:18 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:24 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:30 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:33 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
7:18 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
5:00 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:30 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:55 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:56 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:05 PM | Akero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:30 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
6:30 AM | Akero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
4:31 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
11:58 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:00 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
8:30 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
6:54 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
5:05 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:03 AM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:14 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:14 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:52 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:43 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:08 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025
8:35 PM | Akero Therapeutics (Subject)
| Form FWP | |
01/27/2025
5:07 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:53 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025
3:23 PM | Akero Therapeutics (Subject)
Lamy Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:24 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:24 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:06 PM | Akero Therapeutics (Subject)
Rolph Timothy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
7:31 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
6:38 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
1:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
7:20 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:59 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
12/18/2024
8:01 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
8:03 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
8:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:50 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:52 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
7:56 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:38 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:44 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:24 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
